Facto MI

Facto Market Research offers global market research solutions that often involve actionable market insights and deep research. We provide a comprehensive suite of services to fit the need of each clients and addresses issues being confronted by individual industries.
MarkJohnson by MarkJohnson @
Autotransfusion is a process of blood transfusion where the blood of the patient is extracted from the site of wound, which then gets filtered and purified. This blood is then infused back to the patients’ body. Autotransfusion is used in several surgeries such as cardiovascular surgery, orthopedic surgeries, surgeries related to trauma and during liver and other types of transplantation. The global autotransfusion devices and consumables market was valued at $864 million in 2018, and is estimated to reach $1,380 million by 2025, growing at a CAGR of 6.1% from 2019 to 2026.

The increase in the use of autotransfusion devices and consumables is due to its advantages over allogeneic techniques in preventing the risk of transfusion transmitted infection. In addition, the increase in the prevalence of cardiovascular diseases, trauma, transplantation and rise in technological advancements in blood transfusion techniques drive the autotransfusion devices and consumables market growth and is expected to follow the trend throughout the forecast period. Moreover, increase in government initiatives and focus on safe autotransfusion programs boosts the market growth. However, poor quality purification and improper mixing of blood components and a global shortage of autotransfusion can restrain the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market development.

Get Report Sample Copy @ https://www.factomarketinsights.com/sample/183

This report segments the autotransfusions sales market based on product type, end use, and region to provide a detailed assessment of the market. Based on product type, it is bifurcated into devices and consumables. The devices segment is further categorized into on-pump transfusion devices and off-pump transfusion devices. Based on end use, the market is categorized into hospitals, ambulatory surgical devices, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America is the highest contributor for the growth of autotransfusion devices and consumables market, owing to better healthcare infrastructure and technological advancement in the region along with high disposable incomes and preference over allogenic transfusion techniques by the healthcare professionals and patient population alike. North America is expected to continue this trend during the forecast period. Asia-Pacific is the fastest growing region for the autotransfusion devices and consumables market and is anticipated to remain dominant throughout the forecast period.

KEY BENEFITS FOR STAKEHOLDERS

ü The study provides an in-depth analysis of the autotransfusion devices and consumables market along with the current trends and future estimations to elucidate the imminent investment pockets.
ü A quantitative analysis from 2018 to 2026 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
ü In-depth analysis of market based on product type such as devices and consumables are carried out in the report.
ü The global autotransfusion devices and consumables market scenario is comprehensively analyzed in accordance to the key cities.

Access Complete Research Report with TOC @ https://www.factomarketinsights.com/report/183/autotransfusion-devices-and-consumables-market-amr

KEY MARKET SEGMENTS

By Product Type

Devices
o On-pump Transfusion Devices
o Off-pump Transfusion Devices
• Consumables

By End Use

Hospitals
• Ambulatory Surgical Centres
• Others

By Region

North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

Send an Enquiry @ https://www.factomarketinsights.com/enquiry/183

LIST OF KEY PLAYERS PROFILED IN THE REPORT (DEVICE PROVIDERS)

Becton, Dickinson and Company (C.R. Bard)
• Brightwake Ltd.
• Fresenius
• Getinge AB
• Haemonetics Corporation
• LivaNova PLC
• Medtronic Plc
• Stryker
MarkJohnson by MarkJohnson @
The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart. The prevention of cardiac diseases by monitoring heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS), and others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA, and others. The global cardiac biomarkers testing market has witnessed a greater demand over the past five to six years.

Get Sample Report for Detailed Insights @ https://www.factomarketinsights.com/sample/185

The ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain acts as a key factor that boosts the growth of the global cardiac market. In addition, promising features such as high accuracy, quick outcomes, and economic pricing of cardiac point of care (POC) testing drive the market growth. To keep the momentum of cardiac marker tests, key manufacturers offer customized solutions, thus propelling the growth of the market. The commercial application of multi-menu options for cardiac testing using different combinations of cardiac biomarkers and target-oriented solutions serves as the key opportunity for market expansion. However, limited specificity in some cases and side effects such as skeletal muscle injury restrain the growth of the cardiac biomarkers testing market.

The global cardiac biomarker market is segmented based on type, application, location of testing, and region. By type, the market is fragmented into myocardial muscle creatine kinase (CK-MB), troponins (T and I), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA), and others. Depending on application, it is categorized into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. By location of testing, it is bifurcated into point of care testing and laboratory testing. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

ü This report highlights the market dynamics to understand the global cardiac biomarker market and capitalize on the prevailing opportunities.
ü Quantitative analysis of the current market and forecasts assists stakeholders to design business strategies accordingly.
ü Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
ü Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.

Access Complete Research Report with TOC @ https://www.factomarketinsights.com/report/185/cardiac-biomarkers-testing-market-amr

KEY MARKET SEGMENTS
• By Type
o Myocardial Muscle Creatine Kinase (CK-MB)
o Troponins (T and I)
o Myoglobin
o Brain Natriuretic Peptide (BNPs) or NT-proBNP
o Ischemia-modified Albumin (IMA)
o Others

By Application
o Myocardial Infarction
o Congestive Heart Failure
o Acute Coronary Syndrome
o Atherosclerosis
o Others
By Location of Testing
o Point of Care Testing
o Laboratory Testing
By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• Spain
• Italy
• UK
• Rest of Europe
o Asia-Pacific
• Australia
• Japan
• India
• China
• Rest of Asia-Pacific
o LAMEA
• Latin America
• Middle East
• Africa

Send an Enquiry @ https://www.factomarketinsights.com/enquiry/185

KEY MARKET PLAYERS
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthcare
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• BioMerieux
• PerkinElmer Inc.
• Tosoh Corporation
• Danaher Corporation
• Thermo Fisher Scientific

The other players in the value chain include (profiles not included in the report):

Randox Laboratories
• Johnson and Johnson
• Olympus Corporation
• BG Medicines
• ACS Biomarker B.V.
• Cavadis Biomedical.
MarkJohnson by MarkJohnson @
The global vital organs support systems and medical bionics market size in 2017 is $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 10.9% from 2018 to 2025.

An artificial organ is an engineered device or tissue that is implanted or integrated into a human, interfacing with living tissue. Medical bionics, also known as biomedical implants, are artificial addition to the body. These artificial implants mimic the function of the lost or nonfunctional body part.

Request for Sample Report @ https://www.factomarketinsights.com/sample/186

The vital organs support systems and medical bionics market is expected to exhibit significant growth during the forecast period due to rise in geriatric population, scarcity of donor organs, technological advancements in the artificial organ sector, and increase in R&D expenditure. In addition, rise in number of patients suffering from chronic diseases drives the market growth. However, high cost of artificial organs and stringent approval process are projected to impede growth of the vital organs support systems and medical bionics market. On the contrary, application of advanced biomaterials in artificial organs and lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in the industry.

The global vital organs support systems and medical bionics market is segmented based on product, end user, and region. Depending on product, the market is categorized into vital organs support systems and medical bionics. The vital organs support systems segment is further divided into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics segment is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. Depending on end user, the market is segregated into hospitals, ambulatory surgical centers, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

Browse Complete Research Report with TOC @ https://www.factomarketinsights.com/report/186/vital-organs-support-systems-and-medical-bionics-market-amr

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Product

o Vital organs support systems
§ Artificial Heart
§ Artificial Kidney
§ Artificial Pancreas
§ Artificial Urinary Bladder
§ Artificial Lungs
§ Artificial Liver
o Medical Bionics
o Bionic Eye
o Ear Bionics
§ Cochlear Implants
§ Bone Anchored Hearing Systems
§ Auditory Brainstem Implants
o Orthopedic Bionics
§ Upper limb
§ Lower limb
• Bionic Knee
• Bionic Feet
§ Exoskeleton
§ Electrical Bone Growth Stimulators
• Non-Invasive Bone Growth Stimulators
• Invasive Bone Growth Stimulators
o Cardiac Bionics
§ Pacemaker
• Implantable Pacemaker
• External Pacemaker
§ Ventricular Assist Device
• Left Ventricular Assist Device (LVAD)
• Right Ventricular Assist Device (RVAD)
• Biventricular Assist Device (BIVAD)
§ Artificial Heart Valves
• Mechanical Heart Valves
• Tissue Heart Valves
o Neural Bionics
§ Internal Neurostimulators
• Deep Brain Stimulators (DBS)
• Sacral Nerve Stimulators (SNS)
• Vagus Nerve Stimulators (VNS)
• Spinal Cord Stimulators (SCS)
• Other Neurostimulators

Get Report Sample Copy @ https://www.factomarketinsights.com/sample/186

 
MarkJohnson by MarkJohnson @
The global disposable medical gloves market was valued at $4,047 million in 2017, and is expected to reach $8,444 million by 2025, registering a CAGR of 9.5% during the forecast period. The global disposable medical gloves market is primarily driven by increase in awareness of safety and hygiene amongst healthcare providers and patients. Disposable medical gloves have application in various procedures such as examination, diagnosis, and surgeries. These gloves serve the purpose of protection during various activities that involve toxic chemicals, reactive materials, or unhygienic conditions. Moreover, manufacturing process of certain products such as drugs, require high level of cleanliness and handling of these products is the critical operation that may lead to product contamination if proper care is not taken.

Get Sample Copy for Market Insights @ https://www.factomarketinsights.com/sample/188

The major factors that drive the growth of the disposable medical gloves market include rise in concern for safety and hygiene coupled with the novel manufacturing technologies for making medical gloves temperature-resistant, rupture-resistant, and control latex-associated infections. Healthcare professionals use medical gloves for surgeries and other related activities that are contagious and can be infectious. Thus, due to increase in concern for safety, hygiene, and product quality, the market of disposable gloves foresees a promising growth in the future. However, high competitive pricing offered by local manufacturers is anticipated to hamper the market growth. Moreover, developing and untapped economies are expected to create lucrative opportunities for the disposable medical glove manufacturers in the near future.

The global disposable gloves product market is segmented based on type, form, application, and region. Based on type, the market is segmented into natural rubber gloves, nitrile gloves, vinyl gloves, neoprene gloves, polyethylene gloves, and others. Based on form, the market is bifurcated into powdered and non-powdered form. Based on application, the market is classified into examination and surgical. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

ü The study provides an in-depth analysis of the global disposable gloves market along with the current trends and future estimations to elucidate the imminent investment pockets.
ü Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
ü Comprehensive quantitative analysis of the industry from 2017 to 2025 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
ü Extensive analysis of the key segments of the industry helps in understanding the forms and types of gloves used across the globe.
ü Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Browse Complete Research Report with TOC @ https://www.factomarketinsights.com/report/188/disposable-medical-gloves-market-amr

KEY MARKET SEGMENTS
• By Type
o Natural Rubber Gloves
o Nitrile Gloves
o Vinyl Gloves
o Neoprene Gloves
o Polyethylene Gloves
o Others
• By Form
o Powdered
o Non-powdered
• By Application
o Examination
o Surgical
• By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
o UK
o Germany
o France
o Spain
o Italy
o Rest of Europe
o Asia-Pacific
o Japan
o India
o China
o Australia
o Korea
o Rest of Asia-Pacific
o LAMEA
o Middle East
o Latin America
o Africa
KEY PLAYERS PROFILED
• Top Glove Corporation Berhad
• Supermax Corporation Berhad
• Semperit AG Holding
• Rubberex Corp. M Bhd
• Kossan Rubber Industries Bhd.
• Hartalega Holdings Berhad
• Dynarex Corporation
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• Ansell Limited

Request for Sample Report @ https://www.factomarketinsights.com/sample/188

The other players in the value chain include (profiles not included in the report) the following:

Unigloves (UK) Limited
• Smart Glove Corporation Sdn Bhd
• Cypress Medical Products LLC
• Microflex Corporation
• Mölnlycke Health Care
• YTY Industry Holdings Berhad
MarkJohnson by MarkJohnson @
The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025.

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults.Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs, which results in filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at greatest risk of serious pneumococcal infections and even death.

Get Sample Report for Detailed Insights @ https://www.factomarketinsights.com/sample/189

Thus, Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines, PCV13 and PPSV23. The key factors that drive the growth of the global pneumonia vaccine market include increase in prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high cost associated with the development of such vaccines restrain the market growth. Moreover, development of protein-based combination pneumococcal vaccines is expected to provide lucrative opportunities for the expansion of this market.

The global pneumonia vaccine market is segmented based on type, product, distribution channel, sector, and region. Based on type, the market is bifurcated into pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPV). Products covered in the study include Synflorix, Prevnar 13, PPSV- 23, PCV 13-PIPELINE, V114-MERCK, PCV-20-PFIZER, and PCV-10-SII. Based on distribution channel, the market is categorized into distribution partner companies, non-governmental organizations (NGO), and government authorities. Based on sector, the market is bifurcated into public and private. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Browse Complete Research Report with TOC @ https://www.factomarketinsights.com/report/189/pneumonia-vaccine-market-amr

KEY BENEFITS FOR STAKEHOLDERS

ü The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
ü It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
ü Analysis by type helps understand the various types of pneumonia vaccines used by healthcare providers.
ü Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
ü Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS
By Vaccine Type
• Pneumococcal Conjugate Vaccine
• Pneumococcal Polysaccharide Vaccine
By Product Type
• Prevnar 13
• Synflorix
• Pneumovax 23
By Sector
• Public
• Private
By distribution channel
• Distribution Partner Companies
• Non-governmental Organizations (NGO)
• Government Authorities
By Country
• North America
• Europe
• Asia-Pacific
• LAMEA

Request for Sample Report @ https://www.factomarketinsights.com/sample/189

 
MarkJohnson by MarkJohnson @
The global surgical imaging market generated $1,063 million in 2018, and is projected to reach $1,496 million by 2026, growing at a CAGR of 4.3% from 2019 to 2026. .

Surgical imaging system are intra operative imaging systems that is based on X-ray technology and can be used flexibly in various operating rooms during different surgeries such as orthopedic surgery, traumatology, vascular surgery, neurosurgery, and cardiology for intra-operative imaging.

Request for Sample Report @ https://www.factomarketinsights.com/sample/190

The surgical imaging market is expected to experience significant growth during the forecast period owing to growth in number of minimally invasive surgical procedures across geographies with increase in popularity of flat panel detector c-arms (FPD c-arms), increase in number of hybrid operating rooms is anticipated to significantly boost the growth of the surgical imaging market during the forecast period. Furthermore, increase in demand for integrated imaging systems and technological advancement in surgical imaging systems such as new launch of O-arms n G-arms further contribute toward the market growth. However, higher cost of surgical imaging systems can impede the market growth

The global surgical imaging market is segmented based on modality type, technology, application, and region. Based on modality type, the market is classified as mobile c-arms, mini c-arms, and others. According to technology, the market is categorized as image intensifier c-arms and flat panel detector c-arms (FPD c-arms). Based on application, market divided into neurosurgery, orthopedic & trauma surgery, cardiovascular, general surgery, and other surgeries. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, and rest of Europe), Asia-Pacific (China, Japan, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa and rest of LAMEA).

Outlook Complete Research report with TOC @ https://www.factomarketinsights.com/report/190/surgical-imaging-market-amr

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS
By Modality Type
• Mobile c-arms
• Mini c-arms
• Others
Technology Type
• Image Intensifier c-arms
• Flat panel detector c-arms (FPD c-arms)
Application
• Neurosurgery
• Orthopedic & Trauma Surgery
• Cardiovascular
• General Surgery
• Other Surgery

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Rest of LAMEA

Request for Sample Report @ https://www.factomarketinsights.com/sample/190

 LIST OF KEY PLAYERS PROFILED IN THE REPORT

GE Healthcare (A Subsidiary of General Electric Company)
• GENORAY Co., Ltd.
• Hologic, Inc.
• Koninklijke Philips N.V.
• Medtronic plc.
• SHIMADZU Corp.
• Siemens Healthineers AG
• Toshiba Medical Systems Corporation
• Whale Imaging Inc.
• Ziehm Imaging GmbH
MarkJohnson by MarkJohnson @
Endoscopy is a minimally invasive medical procedure used for diagnosis, prevention, and treatment of complications in visceral organs. The device is either placed in the body through natural openings or cavities (such as anus and mouth) or through incisions, especially in case of arthroscopy. The South Asia flexible endoscope market was valued at $284 million in 2017, and is anticipated to reach $510 million by 2025, registering a CAGR of 7.4%.

Flexible endoscopy devices are equipped with several other parts such as camera or light source at the tip of endoscopes that help physicians or medical professionals to analyze the internal organs of interest. Endoscopy is used to evaluate various conditions such as stomach pain, ulcers, gastritis, digestive tract bleeding, cancerous growth in colon, and changes in bowel habits. Moreover, it is categorized based on the area of the body that are investigated. This includes knee & joints (arthroscopy), lungs (bronchoscopy), colon (colonoscopy), abdominal & pelvic areas (laparoscopy), and others. Increase in the incident rate of targeted diseases such as colon cancer and gastrointestinal disorders propels the demand for endoscopic devices.

Request for Sample Report @ https://www.factomarketinsights.com/sample/199

Surge in geriatric population, which is highly susceptible to pain and chronic disorders, is expected to have a positive impact on the market growth. In addition, rise in need for the development of advanced minimally invasive surgical techniques is expected to augment the demand for endoscopic devices across healthcare settings. This in turn fuels the market growth. However, dearth of trained professionals for handling of endoscopic devices impedes the growth of the market. Conversely, high untapped potential in emerging economies is anticipated to offer significant profitable opportunities for market expansion.

The South Asia flexible endoscope market is segmented based on application into bronchoscopy, laparoscopy, arthroscopy, gastrointestinal endoscopy, urology endoscopy, neuro endoscopy, obstetrics/gynecology endoscopy, ENT endoscopy, and others. Depending on end user, the market is fragmented into hospitals, clinics, and others. Country wise, the market is analyzed across India, Pakistan, Bangladesh, Nepal, Sri Lanka, and rest of Asia.

Key Benefits flexible endoscope market:

The study provides an in-depth analysis of the South Asia flexible endoscope market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report presents a quantitative analysis of the market from 2017 to 2025 to enable stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the market based on application assists in understanding the trends in the industry.
The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

Browse Complete Research Report with TOC @ https://www.factomarketinsights.com/report/199/south-asia-flexible-endoscope-market-amr

flexible endoscope Key Market Segments:

Market by Application

Bronchoscopy
Arthroscopy
Laparoscopy
Urology Endoscopy
Neuro Endoscopy
Gastrointestinal Endoscopy
Obstetrics/Gynecology Endoscopy
ENT Endoscopy
Others

By End User

Hospitals
Clinics
Others

By Country

India
Pakistan
Bangladesh
Sri Lanka
Nepal
Rest of South Asia

Get Sample Report for Detailed Insights @ https://www.factomarketinsights.com/sample/199

The list of key players operating in this market includes:

Boston Scientific Corporation
Conmed Corporation Magnum
Fujifilm Holdings Corporation
Johnson & Johnson (Ethicon, Inc.)
Hoya Corporation
Karl Storz GmbH & Co Kg.
Medtronic Plc
Olympus Corporation
Stryker Corporation
Vimex sp. z.o.o. (Vimex Endoscopy)
MarkJohnson by MarkJohnson @
The hospital and pre-hospital external defibrillators market was valued at $2,260 million in 2017 and is projected to reach $3,737 million by 2025, growing at a CAGR of 6.4% during the forecast period. In terms of volume, the hospital and pre-hospital external defibrillators market accounted for 727 thousand units in 2017 and is projected to reach 1,364 thousand units by 2025, growing at a CAGR of 8.1% during the forecast period.

External defibrillators are light weight and portable devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. These devices are important to deliver a rapid response to the victims of cardiac arrest.

Get Report Sample Copy @ https://www.factomarketinsights.com/sample/203

The external defibrillators market for hospital and pre-hospital is expected to experience significant growth owing to rapid rise in geriatric population with elevated risk of cardiovascular diseases, increase in incidence of cardiovascular diseases, and high presence of unmet medical needs especially in untapped economies, during the forecast period. However, limited insurance coverage and high cost of defibrillators is projected to impede the market growth. However, lucrative opportunities in emerging economies and surge in adoption of external defibrillators in hospital & pre-hospital treatment provide growth opportunities during the forecast period.

The global hospital and pre-hospital external defibrillators market is segmented into type, end user, and region. According to type, the market is bifurcated into manual external defibrillator and automated external defibrillator. Based on end user, the market is categorized into hospital (general wards, ICU, emergency room, and others) and pre-hospital (EMS, fire department, police, private transport companies, and others). Based on region, the market is studied across North America (U.S., and Canada), Latin America (Brazil and Mexico), Europe (Germany, France, the UK, Italy, Spain, Poland, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and rest of Asia-Pacific), and the Middle East and Africa (Saudi Arabia, South Africa, and rest of Middle East and Africa).

Key Benefits for Hospital and Pre-Hospital External Defibrillator Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Browse Complete Research Report with TOC @ https://www.factomarketinsights.com/report/203/hospital-and-pre-hospital-external-defibrillator-market-amr

Hospital And Pre-hospital External Defibrillator Market Key Market Segments:

By Type

Manual Defibrillators
Automated Defibrillators

By End User

Hospitals
General Wards
ICU
Emergency Room (ER)
Others
Pre-Hospital
Emergency Medical Services (EMS)
Fire Departments
Police
Private Transport Companies
Others

By Region

North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Poland
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle-East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa

Get Sample Report @ https://www.factomarketinsights.com/sample/203

List of Key Players Profiled in the Report

Asahi Kasei Corporation
Aurora Capital Group. (Cardiac Science Corporation)
General electric company
Koninklijke Philips N.V.
MEDIANA CORPORATION
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
NIHON KOHDEN CORPORATION.
Progetti srl
SCHILLER AG
STRYKER CORPORATION
MarkJohnson by MarkJohnson @
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.

Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers’ home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. Medical tourists travel to receive medical treatments such as dental treatment, neurological treatment, cardiovascular treatment, and others.

Request for Sample Report @ https://www.factomarketinsights.com/sample/211

The report segments the market into treatment type and region. Based on treatment type, the market is segmented into dental treatment, cosmetic treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and other treatments. Based on region, the medical tourism market is studied across North America (U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (India, China, Indonesia, Singapore, Malaysia, Thailand, South Korea, Taiwan, and, rest of Asia-Pacific), and LAMEA (Brazil, Venezuela, Costa Rica, UAE, South Africa, and rest of LAMEA).

Key Benefits for Medical Tourism Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Request for Research Methodology @ https://www.factomarketinsights.com/method/211

Medical Tourism Key Market Segments:

By Treatment Type

Dental Treatment
Cosmetic Treatment
Cardiovascular Treatment
Orthopedic Treatment
Cardiovascular Treatment
Orthopedic Treatment
Neurological Treatment
Cancer Treatment
Fertility Treatment
Other Treatments

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Indonesia
Singapore
Malaysia
Thailand
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Venezuela
Costa Rica
UAE
South Africa
Rest of LAMEA

Get Sample Report for Market Insights @ https://www.factomarketinsights.com/sample/211

List Of Key Players Profiled in the Report

Apollo Hospitals Enterprise Limited
Fortis Healthcare Limited
Asian Heart Institute
KPJ Healthcare Berhad
NTT Medical Center Tokyo
Seoul National University Hospital
UZ Leuven
Wooridul Spine Hospital
Aditya Birla Memorial Hospital
Barbados Fertility Center
Prince Court Medical Centre
Samitivej PCL.
MarkJohnson by MarkJohnson @
Brain monitoring is the process of identifying any abnormality in the functioning of the brain cells by exploring the structure and function of the brain. These are used to monitor neurological disorders such as Alzheimer’s, Parkinson’s, epilepsy, dementia, multiple sclerosis, sleep disorder, brain tumor, and others. The process involves the use of several brain monitoring devices to track brain functions such as the velocity of blood flow in the veins and arteries in the case of epilepsy and traumatic brain injury. The global brain monitoring market generated $3,850 million in 2017, and is projected to reach $6,595 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025.

Request for Sample Report @ https://www.factomarketinsights.com/sample/227

The global brain monitoring market is expected to register substantial growth in the near future, owing to the increase in the geriatric population and rise in prevalence of neurological disorders. In addition, technological advancements are expected to boost the market growth during the forecast period. However, stringent government regulations and unfavorable reimbursement policies are expected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries is expected to offer remunerative opportunities for the market players. The impact of the driving factors is expected to surpass that of the restraints.

The global brain monitoring market is segmented into product type, procedure, application, and region. By product, the market is categorized into electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices, electromyography (EMG) devices, and accessories. The accessories segmented in further classified into electrodes, sensors, pastes & gels, caps, cables, batteries, and others. Based on procedure, market is bifurcated invasive and non-invasive. Based on application, it is categorized into epilepsy, dementia, Parkinson’s disease, Huntington's disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Browse complete Research Report with TOC @ https://www.factomarketinsights.com/report/227/brain-monitoring-market-amr

KEY BENEFITS FOR STAKEHOLDERS

This report highlights the market dynamics to understand the global brain monitoring market and capitalize on the prevailing opportunities.

Quantitative analysis of the current market and forecasts would assist stakeholders to design business strategies accordingly.

Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.

Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.

KEY MARKET SEGMENTS

By Product Type

Electroencephalography (EEG) Devices
Magnetoencephalography (MEG) Devices
Transcranial Doppler (TCD) Devices
Intracranial Pressure (ICP) Monitors
Cerebral Oximeters
Magnetic Resonance Imaging (MRI) Devices
Computerized Tomography (CT) Devices
Positron Emission Tomography (PET) Devices
Sleep Monitoring Devices
Electromyography (EMG) Devices
Accessories
Electrodes
Sensors
Pastes and Gels
Caps
Cables
Batteries
Others
By Procedure
Invasive
Non-invasive
By Application
Epilepsy
Dementia
Parkinson's Disease
Huntington's Disease
Headache Disorders
Stroke
Traumatic Brain Injuries
Sleep Disorders
Other Diseases
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
Spain
Italy
UK
Rest of Europe
Asia-Pacific
Australia
Japan
India
China
Rest of Asia-Pacific

Get Sample Report @ https://www.factomarketinsights.com/sample/227
12
New Post
feeds Feeds